ursodoxicoltaurine and Sepsis

ursodoxicoltaurine has been researched along with Sepsis* in 2 studies

Other Studies

2 other study(ies) available for ursodoxicoltaurine and Sepsis

ArticleYear
Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice.
    Scientific reports, 2016, 10-03, Volume: 6

    Sepsis-induced lymphopenia is a major cause of morbidities in intensive care units and in populations with chronic conditions such as renal failure, diabetes, HIV and alcohol abuse. Currently, other than supportive care and antibiotics, there are no treatments for this condition. We developed an in vitro assay to understand the role of the ER-stress-mediated apoptosis process in lymphocyte death during polymicrobial sepsis, which was reproducible in in vivo mouse models. Modulating ER stress using chemical chaperones significantly reduced the induction of the pro-apoptotic protein Bim both in vitro and in mice. Furthermore, in a 'two-hit' pneumonia model in mice, we have been able to demonstrate that administration of the chemical chaperone TUDCA helped to maintain lymphocyte homeostasis by significantly reducing lymphocyte apoptosis and this correlated with four-fold improvement in survival. Our results demonstrate a novel therapeutic opportunity for treating sepsis-induced lymphopenia in humans.

    Topics: Animals; Apoptosis; Bcl-2-Like Protein 11; Cell Line; Cell Line, Tumor; Cholagogues and Choleretics; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Humans; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; RAW 264.7 Cells; Sepsis; Survival Analysis; Taurochenodeoxycholic Acid; U937 Cells

2016
Deficiency in Toll-interacting protein (Tollip) skews inflamed yet incompetent innate leukocytes in vivo during DSS-induced septic colitis.
    Scientific reports, 2016, 10-05, Volume: 6

    Functionally compromised neutrophils contribute to adverse clinical outcomes in patients with severe inflammation and injury such as colitis and sepsis. However, the ontogeny of dysfunctional neutrophil during septic colitis remain poorly understood. We report that the dysfunctional neutrophil may be derived by the suppression of Toll-interacting-protein (Tollip). We observed that Tollip deficient neutrophils had compromised migratory capacity toward bacterial product fMLF due to reduced activity of AKT and reduction of FPR2, reduced potential to generate bacterial-killing neutrophil extra-cellular trap (NET), and compromised bacterial killing activity. On the other hand, Tollip deficient neutrophils had elevated levels of CCR5, responsible for their homing to sterile inflamed tissues. The inflamed and incompetent neutrophil phenotype was also observed in vivo in Tollip deficient mice subjected to DSS-induced colitis. We observed that TUDCA, a compound capable of restoring Tollip cellular function, can potently alleviate the severity of DSS-induced colitis. In humans, we observed significantly reduced Tollip levels in peripheral blood collected from human colitis patients as compared to blood samples from healthy donors. Collectively, our data reveal a novel mechanism in Tollip alteration that underlies the inflamed and incompetent polarization of neutrophils leading to severe outcomes of colitis.

    Topics: Adult; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Female; Humans; Intracellular Signaling Peptides and Proteins; Leukocytes; Male; Mice; Middle Aged; Receptors, CCR5; Sepsis; Taurochenodeoxycholic Acid; Young Adult

2016